Steven Gannon is of Fusion Pharmaceuticals Inc.. Currently has a direct ownership of 0 shares of FUSN, which is worth approximately $0. The most recent transaction as insider was on Jun 04, 2024, when has been sold 56,400 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

STEVEN GANNON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 04 2024
SELL
Sale (or disposition) back to the issuer
-
56,400 Reduced 100.0%
0 Common Stock
Aug 11 2022
BUY
Open market or private purchase
$90,132 $2.03 p/Share
44,400 Added 44.05%
56,400 Common Stock
Aug 23 2021
BUY
Open market or private purchase
$22,604 $7.99 p/Share
2,829 Added 19.08%
12,000 Common Stock
Aug 19 2021
BUY
Open market or private purchase
$24,150 $8.05 p/Share
3,000 Added 24.65%
9,171 Common Stock
Aug 18 2021
BUY
Open market or private purchase
$1,377 $8.05 p/Share
171 Added 2.7%
6,171 Common Stock
Aug 16 2021
BUY
Open market or private purchase
$48,600 $8.1 p/Share
6,000 Added 50.0%
6,000 Common Stock

Also insider at

XENE
Xenon Pharmaceuticals Inc. Healthcare
SG

Steven Gannon

Boston, MA

Track Institutional and Insider Activities on FUSN

Follow Fusion Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FUSN shares.

Notify only if

Insider Trading

Get notified when an Fusion Pharmaceuticals Inc. insider buys or sells FUSN shares.

Notify only if

News

Receive news related to Fusion Pharmaceuticals Inc.

Track Activities on FUSN